{"database": "lobbying", "table": "lobbying_activities", "rows": [[782935, "45f410bb-df4e-42f9-affa-68ead5c816d9", "Q2", "HILLCO PARTNERS", 307557, "AMGEN", 2009, "second_quarter", "MMM", "treatment of drugs and biologics under the physician and hospital outpatients rules and other CMS rulemaking", "Centers For Medicare and Medicaid Services (CMS)", 10000, null, 0, 0, "2009-07-07T14:10:00-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["782935"], "units": {}, "query_ms": 0.3745639696717262, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}